small molecule

ANTARA (MICRONIZED)

FENOFIBRATE

Loss of exclusivityMay 2033latest FDA-listed patent expiry
CompanyLupinView the full company profile on CliffBio

Drug detail

Brand nameANTARA (MICRONIZED)
Active ingredientFENOFIBRATE
Strength90MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2013
Marketing statusDISCN

Listed patents

PatentExpiresType
9314447May 2033product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

ANTARA (MICRONIZED) patent cliff — loss of exclusivity May 2033 | CliffBio